Verastem, Inc. to Host NASDAQ Opening in its Cambridge Laboratory May 22, 2012  
5/22/2012 11:16:04 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Verastem, Inc., (NASDAQ:VSTM - News) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced that it will host a remote opening of the NASDAQ Stock Market in its laboratory in Cambridge, MA, on May 22, 2012. This marks the first time that a NASDAQ opening will take place from inside the laboratory of a biopharmaceutical company.